CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
This Quarter Return
-20.86%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$711M
AUM Growth
+$711M
(-29%)
Cap. Flow
-$72M
Cap. Flow
% of AUM
-10.13%
Top 10 Holdings %
Top 10 Hldgs %
83.62%
Holding
33
New
5
Increased
15
Reduced
7
Closed
4
Top Buys
| 1 |
Vanda Pharmaceuticals
VNDA
|
$16.2M |
| 2 |
OSIR
Osiris Therapeutics, Inc. Common Stock
OSIR
|
$15.9M |
| 3 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
$12.6M |
| 4 |
AbbVie
ABBV
|
$8M |
| 5 |
INSY
Insys Therapeutics, Inc.
INSY
|
$7.77M |
Top Sells
| 1 |
United Therapeutics
UTHR
|
$67.4M |
| 2 |
Enanta Pharmaceuticals
ENTA
|
$24.2M |
| 3 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$23.7M |
| 4 |
Celldex Therapeutics
CLDX
|
$19M |
| 5 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
$12.1M |
Sector Composition
| 1 | Healthcare | 84.53% |
| 2 | Technology | 0.52% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVFM
26
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $987K | 0.14% | +122,271 | New | +$987K |
|
27
Axogen
AXGN
$743M
| $925K | 0.13% | +224,400 | New | +$925K |
|
|
CTIC
28
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $672K | 0.09% | +460,000 | New | +$672K |
|
|
SIEN
29
DELISTED
Sientra, Inc.
SIEN
| $606K | 0.09% | 59,664 -72,471 | -55% | -$736K |
|
|
30
Celldex Therapeutics
CLDX
$1.47B
| – | – | -751,748 | Closed | -$19M |
|
31
eHealth
EHTH
$118M
| – | – | -5,242 | Closed | -$67K |
|
|
32
United Therapeutics
UTHR
$13.8B
| – | – | -387,186 | Closed | -$67.4M |
|
|
TVTY
33
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| – | – | -1,010,025 | Closed | -$12.1M |
|